Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Biological Therapy/methods"'
Autor:
Caroline Trang, Salima Hacein-Bey Abina, Malin Ryner, Florian Deisenhammer, Manuel Comabella, Abiba Doukani, Philippe Broët, Anna Fogdell-Hahn, Julianne Duhaze, Hans-Peter Hartung, Clemens Warnke, Natacha Szely, Delphine Bachelet, Alessandra Vultaggio, Bernd C. Kieseier, Sebastian Spindeldreher, Olivier Brocq, Poul Erik Hyldgaard-Jensen, Michael Auer, Marc Pallardy, Matthieu Allez, Mary Birchler, Tom W J Huizinga, Yehuda Chowers, Yoram Bouhnik, Dorothea Buck-Martin, Elizabeth C. Jury, Amy Loercher, Dan Sikkema, Aude Gleizes, Tobias Derfuss, Jessica J Manson, Guillaume Cadiot, Claudia Sievers, Michael Khalil, Naoimh Donnellan, Raija L.P. Lindberg, Agnès Hincelin Mery, Badreddine Mohand Oumoussa, Enrico Maggi, Martin Soubrier, Kathleen Ingenhoven, Orhan Aktas, Sophie Tourdot, Xavier Montalban, Maria Nachury, Niek de Vries, Timothy P. Hickling, Christophe Richez, Bernhard Hemmer, Franck Carbonnel, Finn Sellebjerg, Jérôme Avouac, Petra Nytrova, Xavier Mariette, Anna Lauren, Signe Hässler, Pierre Dönnes, Eva Havrdova, Michael Guger, Claudia Mauri
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS Medicine
PLoS Medicine, 17(10). PUBLIC LIBRARY SCIENCE
PLoS Medicine, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
Hässler, S, Bachelet, D, Duhaze, J, Szely, N, Gleizes, A, Hacein-Bey Abina, S, Aktas, O, Auer, M, Avouac, J, Birchler, M, Bouhnik, Y, Brocq, O, Buck-Martin, D, Cadiot, G, Carbonnel, F, Chowers, Y, Comabella, M, Derfuss, T, De Vries, N, Donnellan, N, Doukani, A, Guger, M, Hartung, H-P, Kubala Havrdova, E, Hemmer, B, Huizinga, T, Ingenhoven, K, Hyldgaard-Jensen, P E, Jury, E C, Khalil, M, Kieseier, B, Laurén, A, Lindberg, R, Loercher, A, Maggi, E, Manson, J, Mauri, C, Mohand Oumoussa, B, Montalban, X, Nachury, M, Nytrova, P, Richez, C, Ryner, M, Sellebjerg, F, Sievers, C, Sikkema, D, Soubrier, M, Tourdot, S, Trang, C, Vultaggio, A & ABIRISK Consortium 2020, ' Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease : A prospective multicohort study of the ABIRISK consortium ', PLoS Medicine, vol. 17, no. 10, e1003348 . https://doi.org/10.1371/journal.pmed.1003348
PLoS Medicine, Public Library of Science, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
PLoS Medicine, Vol 17, Iss 10, p e1003348 (2020)
PLoS medicine, 17(10):e1003348. Public Library of Science
Universitat Autònoma de Barcelona
PLoS Medicine
PLoS Medicine, 17(10). PUBLIC LIBRARY SCIENCE
PLoS Medicine, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
Hässler, S, Bachelet, D, Duhaze, J, Szely, N, Gleizes, A, Hacein-Bey Abina, S, Aktas, O, Auer, M, Avouac, J, Birchler, M, Bouhnik, Y, Brocq, O, Buck-Martin, D, Cadiot, G, Carbonnel, F, Chowers, Y, Comabella, M, Derfuss, T, De Vries, N, Donnellan, N, Doukani, A, Guger, M, Hartung, H-P, Kubala Havrdova, E, Hemmer, B, Huizinga, T, Ingenhoven, K, Hyldgaard-Jensen, P E, Jury, E C, Khalil, M, Kieseier, B, Laurén, A, Lindberg, R, Loercher, A, Maggi, E, Manson, J, Mauri, C, Mohand Oumoussa, B, Montalban, X, Nachury, M, Nytrova, P, Richez, C, Ryner, M, Sellebjerg, F, Sievers, C, Sikkema, D, Soubrier, M, Tourdot, S, Trang, C, Vultaggio, A & ABIRISK Consortium 2020, ' Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease : A prospective multicohort study of the ABIRISK consortium ', PLoS Medicine, vol. 17, no. 10, e1003348 . https://doi.org/10.1371/journal.pmed.1003348
PLoS Medicine, Public Library of Science, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
PLoS Medicine, Vol 17, Iss 10, p e1003348 (2020)
PLoS medicine, 17(10):e1003348. Public Library of Science
Background Biopharmaceutical products (BPs) are widely used to treat autoimmune diseases, but immunogenicity limits their efficacy for an important proportion of patients. Our knowledge of patient-related factors influencing the occurrence of antidru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f38afd466f71b9ab3ba9e7e10f54091
https://doi.org/10.1371/journal.pmed.1003348
https://doi.org/10.1371/journal.pmed.1003348
Autor:
Megan Cann, Andrew D. Dick, Catherine Guly, Fatima Rashed, Andrew A Crawford, Athimalaipet V Ramanan, Sarah L N Clarke
Publikováno v:
Pediatric Rheumatology Online Journal
Cann, M, Ramanan, A V, Crawford, A, Dick, A D, Clarke, S L N, Rashed, F & Guly, C M 2018, ' Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy ', Pediatric Rheumatology, vol. 16, no. 1, pp. 51 . https://doi.org/10.1186/s12969-018-0266-5
Pediatric Rheumatology Online Journal, Vol 16, Iss 1, Pp 1-9 (2018)
Cann, M, Ramanan, A V, Crawford, A, Dick, A D, Clarke, S L N, Rashed, F & Guly, C M 2018, ' Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy ', Pediatric Rheumatology, vol. 16, 51 . https://doi.org/10.1186/s12969-018-0266-5
Cann, M, Ramanan, A V, Crawford, A, Dick, A D, Clarke, S L N, Rashed, F & Guly, C M 2018, ' Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy ', Pediatric Rheumatology, vol. 16, no. 1, pp. 51 . https://doi.org/10.1186/s12969-018-0266-5
Pediatric Rheumatology Online Journal, Vol 16, Iss 1, Pp 1-9 (2018)
Cann, M, Ramanan, A V, Crawford, A, Dick, A D, Clarke, S L N, Rashed, F & Guly, C M 2018, ' Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy ', Pediatric Rheumatology, vol. 16, 51 . https://doi.org/10.1186/s12969-018-0266-5
BACKGROUND: There is a paucity of data on the ocular outcomes in paediatric non-infectious uveitis since the introduction of the biologic agents. The purpose of this study was to outline the clinical characteristics of children with non-infectious uv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a8a5f8babc2b863870fbb5ff2a56c4
https://pubmed.ncbi.nlm.nih.gov/30081917
https://pubmed.ncbi.nlm.nih.gov/30081917
Background Rib fracture is the most common result of thoracic traumas. Intrapulmonary shunt, alveolar capillary membrane damage, intra-alveolar hemorrhage, and hypoxia may develop following rib fractures. Therefore, prompt treatment is important. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1ebf4c55eff5fe09d853f232e1c483
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/15715
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/15715
Autor:
Vibor, Milunović, Martina Bogeljić, Patekar, Inga Mandac, Rogulj, Ana, Planinc-Peraica, Slobodanka Ostojić, Kolonić
Publikováno v:
Liječnički vjesnik
Volume 138
Issue 11-12
Volume 138
Issue 11-12
Limfom plaštene zone (engl. Mantle cell lymphoma – MCL) četvrti je najučestaliji ne-Hodgkinov limfom. Karakteriziran je agresivnim tokom s multiplim relapsima. Cilj je rada literaturnim pregledom opisati suvremeni pristup liječenju ovog limfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::01978ef80e8abf7e122c831a79a8f0a3
https://hrcak.srce.hr/173555
https://hrcak.srce.hr/173555
Publikováno v:
Current Opinion in Microbiology
Current Opinion in Microbiology, Elsevier, 2013, 16 (3), pp.284-292. ⟨10.1016/j.mib.2013.06.008⟩
Current Opinion in Microbiology, 2013, 16 (3), pp.284-292. ⟨10.1016/j.mib.2013.06.008⟩
Current Opinion in Microbiology, Elsevier, 2013, 16 (3), pp.284-292. ⟨10.1016/j.mib.2013.06.008⟩
Current Opinion in Microbiology, 2013, 16 (3), pp.284-292. ⟨10.1016/j.mib.2013.06.008⟩
International audience; Probiotic foods can affect large parts of the population, while therapeutic applications have a less wide scope. While commercialization routes and regulatory requirements differ for both applications, both will need good scie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78665fe70ee64ad53ecdf07139050e3
https://hal.archives-ouvertes.fr/hal-03300727
https://hal.archives-ouvertes.fr/hal-03300727
Autor:
Cornelius Van de Velde, Eric Van Cutsem, Arnaud Roth, Florian Lordick, Stefano Cascinu, Claus-Henning Köhne, Matti Aapro
Publikováno v:
European Journal of Cancer, Vol. 44, No 2 (2008) pp. 182-94
A multidisciplinary approach is mandatory for patients with gastric cancer. Patients should be managed by an experienced team of physicians. The outcome of patients is related to the experience of the multidisciplinary team. Surgery is the cornerston
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfff7563dd22eaabc187749297829b37
https://pubmed.ncbi.nlm.nih.gov/18093827
https://pubmed.ncbi.nlm.nih.gov/18093827